PROREPAIR-A: Clinical and molecular characterization study of prostate cancer (PC) patients with and without previously known germline BRCA1/2 mutations.

被引：0
|
作者：
Lozano, Rebeca
Castro, Elena
Aragon, Isabel
Thorne, Heather
Lopez-Campos, Fernando
Sanz, Alejandro
Alonso, Concepcion
Anido, Urbano
Maria Jose, Juan
Gutierrez Pecharroman, Ana
Ramirez-Backhaus, Miguel
Balmana Gelpi, Judith
Chirivella, Isabel
Llort, Gemma
Romero-Laorden, Nuria
Arevalo, Sara
Rubio, Jose
Di Domenico, Tomas
Kaur Sandhu, Shahneen
Olmos, David
机构：
[1] Spanish Natl Canc Res Ctr, Prostate Canc Clin Res Unit, Madrid, Spain
[2] Hosp Virgen Victoria & Reg Malaga, Inst Invest Biomed Malaga, Malaga, Spain
[3] Inst Biomed Res Malaga IBIMA, Genitourinary Canc Traslat Res Unit, Malaga, Spain
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Ramon Y Cajal Univ Hosp, Radiat Oncol Dept, Madrid, Spain
[6] CNIO, Spanish Natl Canc Res Ctr, Madrid, Spain
[7] Hosp Univ Princesa, Madrid, Spain
[8] Complejo Hosp Univ Santiago de Compostela, Santiado De Complostela, Spain
[9] Inst Valenciano Oncol, Valencia, Spain
[10] Hosp Univ Mostoles, Madrid, Spain
[11] Hosp Univ Vall dHebron, Vall dHebron Inst Oncol, Dept Med Oncol, Barcelona, Spain
[12] Hosp Clin Univ, Dept Med Oncol, INCLIVA, Valencia, Spain
[13] Sanitaria Univ Parc Tauli, Hereditary Canc Unit, Sabadell, Spain
[14] Sanitaria Univ Parc Tauli, Med Oncol Dept, Sabadell, Spain
[15] Hosp Donostia, Guipuzcoa, Spain
[16] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5511
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Outcomes of breast cancer patients with and without BRCA1/2 mutations
    Fatouros, Michael
    Ziogas, Dimosthenis
    Roukos, Dimitrios H.
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (08) : 1918 - 1919
  • [32] A prospective study about BRCA1/BRCA2 germline mutations in hereditary breast/ovarian cancer patients
    Ben Kridis, W.
    Ben Ayed-Guerfali, D.
    Ammous-Boukhris, N.
    Ayedi, W.
    Charfi, S.
    Boudawara, T.
    Daoud, J.
    Khanfir, A.
    Mokdad-Gargouri, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S1223 - S1223
  • [33] SWOG S2210: A phase II study of neoadjuvant carboplatin for localized, high-risk prostate cancer with germline BRCA1/2 mutations.
    Cheng, Heather H.
    Callis, Samuel
    Lin, Daniel W.
    Yu, Evan Y.
    Dorff, Tanya B.
    Kase, Adam McLain
    Tangen, Catherine
    Petrylak, Daniel P.
    Lerner, Seth P.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : TPS354 - TPS354
  • [34] Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients
    Aydemir, AEM
    Luleci, G
    Ozcelik, T
    Colak, T
    Schayek, H
    Akaydin, M
    Friedman, E
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 387 - 387
  • [35] Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients
    D. Torres
    J. Lorenzo Bermejo
    M. U. Rashid
    I. Briceño
    F. Gil
    A. Beltran
    V. Ariza
    U. Hamann
    Scientific Reports, 7
  • [36] Germline mutations in BRCA1 and BRCA2 genes among Sardinian breast cancer patients
    Palomba, G.
    Cossu, A.
    Budroni, M.
    Dedola, M. F.
    Contu, A.
    Farris, A.
    Pisano, M.
    Satta, M. P.
    Sini, M. C.
    Baldinu, P.
    Manca, A.
    Tanda, F.
    Friedman, E.
    Palmieri, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI26 - XI26
  • [37] Tubo-Ovarian Cancer Histoypes in Patients With Germline BRCA1 or BRCA2 Mutations
    Gilks, C. Blake
    McCluggage, W. Glenn
    Brady, Aidan
    Singh, Naveena
    Hunstman, David
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Rahimi, Kurosh
    LABORATORY INVESTIGATION, 2015, 95 : 286A - 286A
  • [38] Tubo-Ovarian Cancer Histotypes in Patients With Germline BRCA1 or BRCA2 Mutations
    Gilks, C. Blake
    McCluggage, W. Glenn
    Brady, Aidan
    Singh, Naveena
    Huntsman, David
    Provencher, Diane
    Mes-Masson, Anne-Marie
    Rahimi, Kurosh
    MODERN PATHOLOGY, 2015, 28 : 286A - 286A
  • [39] Germline BRCA1 and BRCA2 mutations in Brazilian ovarian and breast cancer patients.
    Maistro, Simone
    Encinas, Giselly
    Nagy, Tauana
    Teixeira, Natalia
    Katayama, Maria Lucia H.
    Gouvea, Ana Carolina R. C.
    Diz, Maria del Pilar E.
    Chammas, Roger
    de Boch, Geertruida H.
    Folgueira, Maria Aparecida A. K.
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 31 - 31
  • [40] Clinical and familial characteristics of patients with double heterozygosity in BRCA1 and BRCA2 germline mutations
    Lavie, O.
    Goldberg, Y.
    Gemer, O.
    Segev, Y.
    Dishone, S.
    Leijbkowicz, F.
    Rennert, G.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S83 - S83
12345